Find News

Filter articles

Applied Filters

Showing 1 to 10 of 727 results

EU backs compulsory licensing for COVID vaccines

China, EU, India, South Africa, US08-06-2021Alex Baldwin

The European Union has submitted a new proposal to the World Trade Organisation, which backs compulsory licensing agreements for COVID-19 vaccines when negotiations fail.

Bardehle opens Paris life sciences practice with two hires

France01-06-2021Alex Baldwin

Munich-based firm Bardehle Pagenberg has established a life sciences practice at its Paris office with two recent hires.

UC Berkeley loses CRISPR patent at EPO

EU25-05-2021Muireann Bolger

The University of California Berkeley has lost a CRISPR patent in Europe in the latest twist in the long-running IP saga over the gene-editing technology.

Sanofi and C4X in $493m licensing deal

EU13-04-2021Rory O'Neill

UK company C4X Discovery has agreed an exclusive licensing deal with Sanofi worth a potential €414 million, which will see the French pharmaceutical company develop anti-inflammatory therapies.

Lundbeck loses €150m pay-for-delay appeal

EU30-03-2021Alex Baldwin

Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.

UK implored to back COVID-19 IP waiver at WTO

11-03-2021Muireann Bolger

The UK has been urged to back a proposed IP waiver related to COVID-19 treatments before the World Trade Organisation by business leaders, academics, economists and trade unions.

Five minutes with… Penny Gilbert


The fallout from the landmark Regeneron v Kymab is still being weighed by the UK life sciences community.

AstraZeneca to buy Alexion for $39bn

UK, US14-12-2020Sarah Morgan

AstraZeneca has announced it will acquire Boston-based biopharmaceutical company Alexion Pharmaceuticals, in what is potentially the biggest life sciences deal of this year. 

Danish university sues Creative Biolabs over ‘antibody pirating’

Denmark, US09-12-2020Sarah Morgan

The University of Southern Denmark has accused biotech Creative Biolabs of infringing its patent-protected monoclonal antibody, HG-HYB 7-5. 

MSF urges EU to rid market of ‘avoidable suffering’ from SPCs

30-11-2020Rory O'Neill

Médecins Sans Frontières has warned that the European Commission’s commitment to the supplementary protection certificate system risks undermining its promise to improve drug accessibility.

Showing 1 to 10 of 727 results